PPB Approval

OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML

Registration Code

HK-67765

Sale Requirement

Prescription only Medicines

Registration Date

March 2, 2023

Company NameROCHE HONG KONG LIMITED

Company Information

Company Details

Company NameROCHE HONG KONG LIMITED

Company Address

22/F, CTF LIFE TOWER, 18, SHEUNG YUET ROAD, KOWLOON BAY, KOWLOON

Active Ingredients

Ingredient Name

ocrelizumab

Drug Monographs

English NameOcrelizumab

Chinese Name

奥瑞利珠单抗

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML - PPB 批准文号 | MedPath